FHIR IG analytics| Package | fhir.ke.nccp |
| Resource Type | PlanDefinition |
| Id | PlanDefinition-OncologyPlanDefinitionExample.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/IntelliSOFT-Consulting/nccpFHIRIG/PlanDefinition-OncologyPlanDefinitionExample.html |
| URL | https://nshr-uat.sha.go.ke/fhir/PlanDefinition/OncologyPlanDefinitionExample |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-06-08T10:30:33+00:00 |
| Title | AC-T Chemotherapy Regimen (21-day cycles) |
| Realm | us |
| Authority | hl7 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Regimen template for AC-T: Doxorubicin + Cyclophosphamide → Paclitaxel, 8 × 21-day cycles
{
"resourceType": "PlanDefinition",
"id": "OncologyPlanDefinitionExample",
"meta": {
"profile": [
"https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-oncology-plan-definition"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-planned-cycles-extension",
"valueInteger": 8
},
{
"url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-length-days-extension",
"valueInteger": 21
}
],
"url": "https://nshr-uat.sha.go.ke/fhir/PlanDefinition/OncologyPlanDefinitionExample",
"identifier": [
{
"system": "https://nshr-uat.sha.go.ke/fhir/regimen-id",
"value": "REG-AC-T-V1"
}
],
"version": "0.1.0",
"title": "AC-T Chemotherapy Regimen (21-day cycles)",
"type": {
"coding": [
{
"system": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/plan-definition-type-cs",
"code": "REGIMEN-TEMPLATE",
"display": "Regimen Template"
}
]
},
"status": "active",
"date": "2026-06-08T10:30:33+00:00",
"publisher": "Digital Health Agency (DHA), Kenya",
"contact": [
{
"name": "Digital Health Agency (DHA), Kenya",
"telecom": [
{
"system": "url",
"value": "https://dha.go.ke"
},
{
"system": "email",
"value": "info@dha.go.ke"
}
]
},
{
"name": "Digital Health Agency Kenya – FHIR Team",
"telecom": [
{
"system": "email",
"value": "info@dha.go.ke",
"use": "work"
},
{
"system": "url",
"value": "https://dha.go.ke",
"use": "work"
}
]
}
],
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "KE",
"display": "Kenya"
}
]
}
],
"action": [
{
"title": "Doxorubicin 60 mg/m² IV — Day 1"
},
{
"title": "Cyclophosphamide 600 mg/m² IV — Day 1"
}
]
}